ロード中...
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
Rationale: The expression of the chemokine (C-X-C motif) ligand 1 (CXCL1), an inflammatory protein, has been reported to be up-regulated in many human cancers. The mechanisms through which aberrant cellular CXCL1 levels promote specific steps in tumor growth and progression are unknown. Methods: We...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6376461/ https://ncbi.nlm.nih.gov/pubmed/30809313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.29553 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|